Skip to main content Accessibility help
×
Home
  • Print publication year: 2010
  • Online publication date: March 2011

Chap 1 - OVERVIEW OF SOFT TISSUE TUMORS

Summary

DEFINITION

Soft tissue tumors are generally defined as tumors of connective tissues, including nonosseous sarcomas, benign mesenchymal tumors, and tumor-like proliferations. These tumors are usually considered to include non-osseous tumors of the extremities, trunk wall, intraabdominal and intrathoracic space, and head and neck, although definitions vary. Generally excluded from this definition are nonmesenchymal tumors of the skin, cutaneous melanoma, most primary epithelial tumors, and brain and bone tumors.

In this book, soft tissue is understood broadly to include any important tumors of nonbony tissues of the extremities, trunk wall, retroperitoneum, mediastinum, and head and neck, except organ-specific tumors. Gastrointestinal stromal tumors are included because of their clinical importance and common occurrence as metastatic abdominal masses. Cutaneous nevi and primary cutaneous melanoma and intracranial nerve sheath tumors have been excluded. Metastatic epithelial tumors and metastatic melanoma are included because of their practical importance (Table 1.1). As a subspecialty, soft tissue pathology intersects many other subspecialties of pathology.

CLASSIFICATION

The purpose of classification is to group similar tumors to create an understanding of tumor biology and behavior for developing treatment and follow-up strategies. The study of properly classified tumors also aids in the discovery of pathogenesis, devising biology-based treatments, and perhaps preventing tumors.

Soft tissue tumors continue to be classified according to the cell type that they resemble or have been thought to resemble.

REFERENCES
Fletcher, CDM, Unni, KK, Mertens, F (eds). Pathology and genetics. Tumors of soft tissue and bone. IARC Press, Lyon, 2002.
Ferrari, G, Cusella-De Angelis, G, Coletta, M, Paolucci, E, Stornaiulo, A, Cossu, G, Mavilio, F. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 1998;279:1528–1530.
Asahara, T, Masuda, H, Takahashi, T, Kalka, C, Pastore, C, Silver, M. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999;85:221–228.
Jemal, A, Siegel, R, Ward, E, Hao, Y, Xu, J, Murray, T. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71–96.
Zahm, SH, Fraumeni, JF. The epidemiology of soft tissue sarcoma. Semin Oncol 197:24;504–514.
Ross, JA, Severson, RK, Davis, S, Brooks, JJ. Trends in the incidence of soft tissue sarcomas in the United States from 1973 through 1987. Cancer 1993;72:486–490.
Clemente, C, Orazi, A, Rilke, F. The Italian registry of soft tissue tumors. Appl Pathol 1988;6:221–240.
Olsson, H. A review of the epidemiology of soft tissue sarcoma. Acta Orthop Scand (Suppl 285) 1999;70:8–19.
Laskin, WB, Silverman, TA, Enzinger, FM. Postirradiation soft tissue sarcomas: An analysis of 53 cases. Cancer 1988;62:2230–2240.
Wiklund, TA, Blomqvist, CP, Räty, J, Elomaa, I, Rissanen, P, Miettinen, M. Postirradiation sarcoma: Analysis of a nationwide cancer registry material. Cancer 1991;68:524–531.
Mark, RJ, Poen, J, Tran, LM, Fu, YS, Selch, MT, Parker, RG. Postirradiation sarcomas. A single-institution study and review of the literature. Cancer 1994;73:2653–2662.
Stover, BJ. Effect of thorothrast in humans. Health Phys 1983;44 Suppl 1:253–257.
Boshoff, C, Chang, Y. Kaposi's sarcoma-associated herpesvirus: a new DNA tumor virus. Annu Rev Med 2001;52:453–470.
Hsu, JL, Glaser, SL. Epstein-Barr virus-associated malignancies: epidemiologic patterns and etiologic implications. Crit Rev Oncol Hematol 2000;34:27–53.
Jennings, TA, Peterson, L, Axiotis, CA, Friedlaender, GE, Cooke, RA, Rosai, J. Angiosarcoma associated with foreign body material: A report of three cases. Cancer 1988;62:2436–2444.
Kirkpatrick, CJ, Alves, A, Köhler, H, Kriegsmann, J, Bittinger, F, Otto, M, Williams, DF, Eloy, R. Biomaterial-induced sarcoma: A novel model to study preneoplastic change. Am J Pathol 2000;156:1455–1467.
Falk, H, Thomas, LB, Popper, H, Ishak, KG. Hepatic angiosarcoma associated with androgenic-anabolic steroids. Lancet 1979;2:1120–1123.
Kilpatrick, SE. Histologic prognostication in soft tissue sarcomas: Grading versus subtyping or both? A comprehensive review of the literature with proposed practical guidelines. Ann Diagn Pathol 1999;3:48–61.
Oliveira, AM, Nascimento, AG. Grading in soft tissue tumors: principles and problems. Skeletal Radiol 2001;30:543–559.
Deyrup, AT, Weiss, SW. Grading of soft tissue sarcomas: the challenge of providing information in an imprecise world. Histopathology 2006;48:42–50.
Coindre, JM. Grading of soft tissue sarcomas: Review and update. Arch Pathol Lab Med 2006;130:1448–1453.
Trojani, M, Contesso, G, Coindre, JM. Soft-tissue sarcomas of adults: study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer 1984;33:37–42.
Coindre, JM, Bui, NB, Bonichon, F, Mascarel, I, Trojani, M. Histopathologic grading in spindle cell soft tissue sarcomas. Cancer 1988;61:2305–2309.
Costa, J, Wesley, RA, Glatstein, E, Rosenberg, SA. The grading of soft tissue sarcomas: Results of a clinicohistopathologic correlation in a series of 163 cases. Cancer 1984;53: 530–541.
Guillou, L, Coindre, JM, Bonichon, F. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol 1997;15:350–362.
Parham, DM, Webber, BL, Jenkins, JJ, Cantor, AB, Maurer, HM. Nonrhabdomyosarcomatous soft tissue sarcomas of childhood: formulation of a simplified system for grading. Mod Pathol 1995;8:705–710.
Markhede, G, Angervall, L, Stener, B. A multivariate analysis of the prognosis after surgical treatment of malignant soft tissue tumors. Cancer 1982;49:1721–1733.
Myhre-Jensen, O, Kaae, S, Madsen, EH, Sneppen, O. Histopathological grading in soft tissue tumours: Relation to survival in 261 surgically treated patients. Acta Pathol Microbiol Scand A 1983;91:145–150.
Gustafson, P, Akerman, M, Alvegord, TA, Coindre, JM, Fletcher, CD, Rydholm, A. Prognostic information in soft tissue sarcoma using tumour size, vascular invasion and microscopic tumour necrosis – the SIN-system. Eur J Cancer 2003;39:1568–1576.
,Association of the Directors of Anatomic and Surgical Pathology: Recommendations for the reporting of soft tissue sarcomas. Mod Pathol 1998;11:1257–1260.
Peabody, TD, Gibbs, CP, Simon, MA. Evaluation and staging of musculoskeletal neoplasms. J Bone Joint Surg 1998;80A:1204–1218.
Sobin, LH, Wittekind, C. TNM classification of malignant tumors. UICC, Wiley-Liss, 2002.
Greene, FL, Page, D, Morrow, M, Balch, C, Haller, D, Fritz, A, Fleming, I, eds. AJCC Cancer Staging Manual, 6th ed. New York: Springer, 2002.
Russell, WO, Cohen, J, Enzinger, F, Hajdu, SI, Heise, H, Martin, RG, Meissner, W, Miller, WT, Schmitz, RL, Suit, HD. A clinical and pathological staging system for soft tissue sarcomas. Cancer 1977;40:1562–1570.
Enneking, WF, Spanier, SS, Goodman, MA. A system for the surgical staging of musuloskeletal tumors. Orthop Rel Res 1980;153:106–120.
Kattan, MW, Laung, DHY, Brennan, MF. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol 2002;20:791–796.
Mariani, L, Miceli, R, Kattan, MW, Brennan, MF, Colecchia, M, Fiore, M. Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three-grade system. Cancer 2005;103:402–408.
Eilber, FC, Brennan, MF, Eilber, FR, Dry, SM, Singer, S, Kattan, MW. Validation of the postoperative nomogram for 12-year sarcoma-specific mortality. Cancer 2004;101:2270–2275.
Dalal, KM, Kattan, MW, Antonescu, CR, Brennan, MF, Singer, S. Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Ann Surg 2006;244:381–391.
Erlandson, RA, Woodruff, JM. Role of electron microscopy in the evaluation of soft tissue neoplasms, with emphasis on spindle cell and pleomorphic tumors. Hum Pathol 1998;29:1372–1981.
Ordonez, MG, Mackay, B. Electron microscopy in tumor diagnosis: Indications for its use in the immunohistochemical era. Hum Pathol 1998;29:1403–1411.